07Sep 2023
Age and C-Peptide Immunoreactivity index  affect fasting blood ketone levels in  type 1 diabetes patients after sodium‐glucose cotransporter 2 inhibitor administration

Age and C-Peptide Immunoreactivity index affect fasting blood ketone levels in type 1 diabetes patients after sodium‐glucose cotransporter 2 inhibitor administration

A recent study examined the use of Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) in individuals with type 1 diabetes, shedding light on potential risks. Results revealed that all 46 Japanese patients with type 1 diabetes experienced increased ketone concentrations after using SGLT2is. Notably, younger age and a low basal-to-bolus insulin ratio were linked to elevated ketone levels. This study underscores the need for careful consideration and patient education when prescribing SGLT2is, especially for younger patients or those with a low CPR index in type 1 diabetes management.

  • #endo-diabetology

Like

Save

Share